(MENAFN- GlobeNewsWire - Nasdaq) LED-based and mobile devices lead the market, with hospitals being primary consumers. Key players include Philips, GE, and Drägerwerk, with Victoria and Queensland being significant contributors.

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Australia Infant Phototherapy Device Market Forecast 2025-2033" has been added to ResearchAndMarkets's offering.
The Australia Infant Phototherapy Device Market is estimated to reach US$ 2.47 billion by 2033, from US$ 1.88 billion in 2024, growing at a CAGR of 3.1% during 2025-2033. This is supported by an increase in cases of neonatal jaundice, increase in awareness about early infant health care, and advances in non-invasive phototherapy treatments in hospitals and neonatal intensive care units in the country.

The major companies profiled in this Australia Infant Phototherapy Device market report include:

• Ningbo David Medical Device Co. Ltd.
• Koninklijke Philips N.V.
• General Electric Company
• Inapiration Healthcare Group PLC
• Dragerwerk AG & Co. KGaA
• Ibis Medical Equipment and Systems Pvt. Ltd.
• Weyer GmbH
• Natus Medical Incorporated

Growth Drivers in Australia's Infant Phototherapy Device Market

Increasing Prevalence of Neonatal Jaundice

Neonatal jaundice is a common disorder in newborns throughout Australia, frequently due to premature birth or immaturity of the liver. Early detection and treatment are prioritized by hospitals and clinics to avert complications such as kernicterus. With more babies being screened on birth, the demand for phototherapy devices is increasing. The higher rate of diagnosis, coupled with increased parental and caregiver awareness, accelerates the demand for effective and non-invasive treatment devices. KPMG reviewed recent Australian Bureau of Statistics figures, a total of 289,100 births in Australia for 2023.

Advances in Phototherapy Devices Technology

The market is experiencing innovation in phototherapy equipment, such as the application of LED technology, fiber-optic phototherapy blankets, and sophisticated intensity controls. These advances provide improved treatment results, energy efficiency, portability, and infant comfort. Australian hospitals are spending more on such innovations, fueling market growth. The replacement of fluorescent-based with LED-based equipment is particularly significant in urban and rural health facilities. In March 2022, Cook Medical launched The MINC+ Benchtop Incubator for clinical embryologists and IVF clinics across Australia. This kind of product launches is anticipated to drive prenatal care in the country, anticipated to drive market growth over the forecast period.

Government Support and Healthcare Infrastructure

Australia's strong public healthcare system, as well as government interventions in neonatal and maternal health, largely facilitate the implementation of infant phototherapy equipment. Public and private hospital procurement inclusion, in addition to funding of rural healthcare outreach, fuel broad access. Programs for training healthcare personnel also ensure proper usage, enhancing results and building trust in their effectiveness nationwide.

Challenges in the Australia Infant Phototherapy Device Market

Expensive Equipment and Budget Restraints

With the advantages, the cost of advanced phototherapy equipment - particularly LED-based equipment - is a challenge for small clinics and rural hospitals. Budget constraints can result in underuse or the use of outdated machines. The absence of centralized procurement regulations in certain regions is also a factor in uneven distribution and late upgrades in lower-income or remote areas.

Limited Availability in Remote and Indigenous Populations

Healthcare access geographic disparities continue to be a significant issue. Remote and Indigenous populations in Australia might not have direct access to neonatal units or phototherapy equipment. Transporting the newborns to larger centers for treatment can create a delay in receiving it and exposes them to greater chances of complications. This gap has to be filled by investing in mobile phototherapy technology and trained staff to cover underserved populations.

Key Attributes

Report Attribute	Details
No. of Pages	200
Forecast Period	2024-2033
Estimated Market Value (USD) in 2024	$1.88 Billion
Forecasted Market Value (USD) by 2033	$2.47 Billion
Compound Annual Growth Rate	3.1%
Regions Covered	Australia

Key Topics Covered
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Australia Infant Phototherapy Device Market
5.1 Historical Market Trends
5.2 Market Forecast
6. Market Share Analysis
6.1 By Light Source
6.2 By Configuration
6.3 By End User
6.4 By States

7. Light Source
7.1 Fluorescent Lamps
7.2 Light Emitting Diodes
7.3 Quartz Halogen Lamps
7.4 Gas Discharge Tubes

8. Configuration
8.1 Mobile Device
8.2 Fixed Device

9. End User
9.1 Hospital
9.2 Neonatal Clinics

10. Top States
10.1 New South Wales
10.2 Victoria
10.3 Queensland
10.4 Western Australia
10.5 South Australia
10.6 Australian Capital Territory
10.7 Tasmania
10.8 Northern Territory

11. Value Chain Analysis
12. Porter's Five Forces Analysis
12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Competition
12.4 Threat of New Entrants
12.5 Threat of Substitutes
13. SWOT Analysis
13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threats
14. Pricing Benchmark Analysis
15. Key Players Analysis

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Australian Infant Phototherapy Device Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN03112025004107003653ID1110285991